Rama Krishna Myneni
Rama Krishna Myneni has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Hareesh Divadari
Stira Pharmaceuticals LLC Fairfield New Jersey USA
2 shared publications - Pranitha Sambu
Aurex Laboratories Pvt Ltd Hyderabad India
2 shared publications - Prasanna Kumar Lankalapalli
Visual Technologies LLC Plano Texas USA
2 shared publications Srinivasulu Kasa
Osmania University Hyderabad India
2 shared publicationsVijaykumar Chollety
Ascent Pharmaceuticals Inc. Central Islip New York USA
2 shared publicationsGovardhan Rao Thalluri
1 shared publication
Latest Publications
- Open Access
- 25 March 2026
- Published by Springer Nature in Discover Chemistry
- Vol. 3 (1)
UPLC-TQ MS method development and validation for N-nitroso-N-desmethyl methadone detection in methadone hydrochloride tablets: a comprehensive analysis
- 25 March 2026
- Published by Springer Nature in Discover Chemistry
- Vol. 3 (1)
Open AccessUPLC-TQ MS method development and validation for N-nitroso-N-desmethyl methadone detection in methadone hydrochloride tablets: a comprehensive analysis
- 26 May 2025
- Published by Wiley in Biomedical Chromatography
- Vol. 39 (7) , e70103
Stability‐Indicating RP‐HPLC Method Development and Validation for Quantification of Butylated Hydroxyanisole Content in Loperamide Oral Solid Dosage Form
The present study discusses the development of a simple, rapid, and specific high‐performance liquid chromatography (HPLC) method for the estimation of butylated hydroxyanisole (BHA) in loperamide HCl capsule dosage formulations. The developed HPLC method was validated in accordance with current ICH guidelines. Chromatographic separation was achieved using a phosphate buffer (pH 6.8) as mobile phase A and a mixture of acetonitrile and buffer in a ratio of 80:20 (v/v) as mobile phase B. The flow rate was 0.8 mL/min, and column temperature was maintained at 35°C. Detection of the component was performed at 290 nm for BHA. The optimized HPLC method was validated as per current ICH guidelines and demonstrated high specificity with a linearity range of 13–83 μg/mL for BHA, with a correlation coefficient greater than 0.999. The method showed accuracy exceeding 97%. Stress studies revealed that BHA is sensitive to peroxide stress conditions. The results highlight the successful applicability of the current method for estimating BHA in marketed formulations, which can be further utilized to evaluate other formulation systems. The developed method was validated according to international ICH guidelines concerning specificity, linearity, precision, and accuracy. The method was developed and validated in a quality control lab for stability analysis.
- 26 May 2025
- Published by Wiley in Biomedical Chromatography
- Vol. 39 (7) , e70103
Stability‐Indicating RP‐HPLC Method Development and Validation for Quantification of Butylated Hydroxyanisole Content in Loperamide Oral Solid Dosage Form
The present study discusses the development of a simple, rapid, and specific high‐performance liquid chromatography (HPLC) method for the estimation of butylated hydroxyanisole (BHA) in loperamide HCl capsule dosage formulations. The developed HPLC method was validated in accordance with current ICH guidelines. Chromatographic separation was achieved using a phosphate buffer (pH 6.8) as mobile phase A and a mixture of acetonitrile and buffer in a ratio of 80:20 (v/v) as mobile phase B. The flow rate was 0.8 mL/min, and column temperature was maintained at 35°C. Detection of the component was performed at 290 nm for BHA. The optimized HPLC method was validated as per current ICH guidelines and demonstrated high specificity with a linearity range of 13–83 μg/mL for BHA, with a correlation coefficient greater than 0.999. The method showed accuracy exceeding 97%. Stress studies revealed that BHA is sensitive to peroxide stress conditions. The results highlight the successful applicability of the current method for estimating BHA in marketed formulations, which can be further utilized to evaluate other formulation systems. The developed method was validated according to international ICH guidelines concerning specificity, linearity, precision, and accuracy. The method was developed and validated in a quality control lab for stability analysis.
- 7 February 2025
- Published by Wiley in Biomedical Chromatography
- Vol. 39 (3) , e6088
Stability‐Indicating RP‐HPLC Method Development and Validation for the Quantification of Fluphenazine Tablets in Solid Oral Dosage Form
The present manuscript discusses the development of simple, rapid, specific, precision, accuracy stability indicating HPLC method for the analysis of fluphenazine tablets dosage form. The chromatographic separation was achieved using 0.02‐M phosphate buffer (pH 3.0) and adjusted with orthophosphoric acid solution as a buffer. We mixed buffer, methanol, and acetonitrile in the ratio of 500:300:200 (v/v/v) as the mobile phase. The detection of component was made at 254 nm for fluphenazine hydrochloride. We evaluated stress studies under different types of ICH conditions. The optimized HPLC method was validated as per the current ICH guidelines. The validated HPLC method was obtained highly specific with linearity ranging between 2.5 and 120 μg/mL of fluphenazine HCl and the correlation coefficient for the drug > 0.999. The method showed more than 97% accuracy. In stress studies, the fluphenazine HCl was found to be sensitive in photolytic stress conditions and oxidation stress condition. It is a typical antipsychotic drug and used for the treatment of schizophrenia and bipolar disorder. The method was found to be suitable for the quality control of fluphenazine hydrochloride in the tablet as well as in stability‐indicating studies. The method was applied to analyze stability samples.
- 7 February 2025
- Published by Wiley in Biomedical Chromatography
- Vol. 39 (3) , e6088
Stability‐Indicating RP‐HPLC Method Development and Validation for the Quantification of Fluphenazine Tablets in Solid Oral Dosage Form
The present manuscript discusses the development of simple, rapid, specific, precision, accuracy stability indicating HPLC method for the analysis of fluphenazine tablets dosage form. The chromatographic separation was achieved using 0.02‐M phosphate buffer (pH 3.0) and adjusted with orthophosphoric acid solution as a buffer. We mixed buffer, methanol, and acetonitrile in the ratio of 500:300:200 (v/v/v) as the mobile phase. The detection of component was made at 254 nm for fluphenazine hydrochloride. We evaluated stress studies under different types of ICH conditions. The optimized HPLC method was validated as per the current ICH guidelines. The validated HPLC method was obtained highly specific with linearity ranging between 2.5 and 120 μg/mL of fluphenazine HCl and the correlation coefficient for the drug > 0.999. The method showed more than 97% accuracy. In stress studies, the fluphenazine HCl was found to be sensitive in photolytic stress conditions and oxidation stress condition. It is a typical antipsychotic drug and used for the treatment of schizophrenia and bipolar disorder. The method was found to be suitable for the quality control of fluphenazine hydrochloride in the tablet as well as in stability‐indicating studies. The method was applied to analyze stability samples.